zavvie Launches HomeFAI: AI-Powered Alternative Financing System Brings Speed and Cash to Win More Deals
Source: zavvie | GlobeNewswire Inc. Cash Advantage program results in 92% mortgage attachment BOULDER, Colo., March 12, 2025...
Mark Cuban Foundation Launches High School Teacher Fellowship Program
Source: Mark Cuban Foundation | GlobeNewswire Inc. DALLAS, March 12, 2025 (GLOBE NEWSWIRE) — The Mark Cuban Foundation...
Mark Cuban Foundation Launches High School Teacher Fellowship Program
Source: Mark Cuban Foundation | GlobeNewswire Inc. DALLAS, March 12, 2025 (GLOBE NEWSWIRE) — The Mark Cuban Foundation...
Mark Cuban Foundation Launches High School Teacher Fellowship Program
Source: Mark Cuban Foundation | GlobeNewswire Inc. DALLAS, March 12, 2025 (GLOBE NEWSWIRE) — The Mark Cuban Foundation...
CAST Announces AI Agent Beta for Tech Debt and Modernization
Source: CAST | GlobeNewswire Inc. AI director executes first-of-a-kind remediation of large application codebase PARIS and NEW YORK,...
CAST Announces AI Agent Beta for Tech Debt and Modernization
Source: CAST | GlobeNewswire Inc. AI director executes first-of-a-kind remediation of large application codebase PARIS and NEW YORK,...
Itron Launches IntelliFLEX Solution to Strengthen Grid Reliability and Optimize Distributed Energy Resource Integration
Source: Itron – Inc. | GlobeNewswire Inc. Groundbreaking Grid-Edge DERMS Solution Enhances Local Resilience, Demand Flexibility and Real-Time...
Itron Launches IntelliFLEX Solution to Strengthen Grid Reliability and Optimize Distributed Energy Resource Integration
Source: Itron – Inc. | GlobeNewswire Inc. Groundbreaking Grid-Edge DERMS Solution Enhances Local Resilience, Demand Flexibility and Real-Time...
Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Harnessing generative AI to develop targeted therapies for DNA damage response,...
Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
Source: Rakovina Therapeutics Inc | GlobeNewswire Inc. Harnessing generative AI to develop targeted therapies for DNA damage response,...